FI932144A0 - Nukleinsyraamplifikation med ett oavbrutet sekvensreplikationssystem omfattande tvao enzymer - Google Patents

Nukleinsyraamplifikation med ett oavbrutet sekvensreplikationssystem omfattande tvao enzymer

Info

Publication number
FI932144A0
FI932144A0 FI932144A FI932144A FI932144A0 FI 932144 A0 FI932144 A0 FI 932144A0 FI 932144 A FI932144 A FI 932144A FI 932144 A FI932144 A FI 932144A FI 932144 A0 FI932144 A0 FI 932144A0
Authority
FI
Finland
Prior art keywords
inbred
enzyme
system containing
replication system
sequence replication
Prior art date
Application number
FI932144A
Other languages
English (en)
Other versions
FI932144A (fi
Inventor
Eoin David Fahy
Deborah Yantis Kwoh
Thomas Raymond Gingeras
Original Assignee
Siska Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siska Diagnostics Inc filed Critical Siska Diagnostics Inc
Publication of FI932144A publication Critical patent/FI932144A/fi
Publication of FI932144A0 publication Critical patent/FI932144A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
FI932144A 1990-11-13 1993-05-12 Nukleinsyraamplifikation med ett oavbrutet sekvensreplikationssystem omfattande tvao enzymer FI932144A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61268890A 1990-11-13 1990-11-13

Publications (2)

Publication Number Publication Date
FI932144A FI932144A (fi) 1993-05-12
FI932144A0 true FI932144A0 (fi) 1993-05-12

Family

ID=24454235

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932144A FI932144A0 (fi) 1990-11-13 1993-05-12 Nukleinsyraamplifikation med ett oavbrutet sekvensreplikationssystem omfattande tvao enzymer

Country Status (13)

Country Link
EP (1) EP0572417A4 (fi)
JP (1) JPH06502767A (fi)
AU (1) AU9131591A (fi)
CA (1) CA2096013A1 (fi)
FI (1) FI932144A0 (fi)
HU (1) HUT69772A (fi)
IE (1) IE913930A1 (fi)
IL (1) IL100040A (fi)
NO (1) NO931709L (fi)
NZ (1) NZ240574A (fi)
PT (1) PT99500A (fi)
WO (1) WO1992008800A1 (fi)
ZA (1) ZA918965B (fi)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994011507A2 (en) * 1992-11-19 1994-05-26 Gingeras Thomas R Production of monoclonal recombinant antibodies without the use of hybridomas by in vitro spleen fragment culture combined with isothermal self-sustained sequence replication of rna
WO1995015399A1 (fr) * 1993-12-01 1995-06-08 Toyo Boseki Kabushiki Kaisha Procede d'amplification et de detection d'une sequence nucleotidique au moyen d'enzymes thermostables
US5705366A (en) * 1994-09-15 1998-01-06 Johnson & Johnson Clinical Diagnostics, Inc. Coamplification of target nucleic acids using volume exclusion agent in reaction composition, test kit and test device useful therefor
JPH08131171A (ja) * 1994-11-11 1996-05-28 Asahi Chem Ind Co Ltd 逆転写酵素の安定化組成物
US5763184A (en) 1996-01-30 1998-06-09 Roche Molecular Systems, Inc. Nucleotide sequence variation in the ABO glycosyltransferase gene
WO2000000638A2 (en) * 1998-06-26 2000-01-06 Akzo Nobel N.V. Tagging of rna amplicons generated by transcription-based amplification
JP2001029078A (ja) * 1999-07-16 2001-02-06 Shimadzu Corp Ｒｎａ増幅法
ATE384731T1 (de) 2000-08-03 2008-02-15 Hoffmann La Roche Nukleinsäurebindende verbindungen mit pyrazolo 3, 4-d pyrimidinanalogen von purin-2,6-diamin und ihre verwendung
US6780588B2 (en) * 2001-05-07 2004-08-24 Applera Corporation Methods for the reduction of stutter in microsatellite amplification
US6841349B2 (en) 2001-05-07 2005-01-11 Applera Corporation Applied Biosystems Group Methods for the reduction of stutter in microsatellite amplification
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
EP1466018B2 (en) 2002-01-08 2015-08-12 Roche Diagnostics GmbH Use of silica material in an amplification reaction
WO2003064679A2 (en) 2002-01-30 2003-08-07 Id Biomedical Corporation Methods for detecting vancomycin-resistant microorganisms and compositions therefor
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
DE10240868A1 (de) * 2002-09-04 2004-03-18 Artus Gesellschaft für molekularbiologische Diagnostik und Entwicklung mbH Verbesserte Verfahren zur Synthese von Nukleinsäuren
DE602004009038T3 (de) 2003-01-29 2015-06-25 Roche Diagnostics Gmbh Verbessertes Verfahren zur Behandlung durch Bisulfit
JP2004357502A (ja) * 2003-05-30 2004-12-24 Olympus Corp 核酸分子を使用した情報処理方法
US20090232771A1 (en) 2004-07-13 2009-09-17 Takeda Pharmaceutical Company Limited Method of controlling cell functions
EP1632578A1 (en) 2004-09-03 2006-03-08 Roche Diagnostics GmbH DNA decontamination method
GB0701253D0 (en) 2007-01-23 2007-02-28 Diagnostics For The Real World Nucleic acid amplification and testing
EP2185726B1 (en) 2007-08-06 2014-01-08 Orion Genomics, LLC Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the igf2 gene
CA2639416C (en) 2007-09-11 2019-12-31 F. Hoffmann-La Roche Ag Diagnostic test for susceptibility to b-raf kinase inhibitors
CA2704447A1 (en) 2007-11-01 2009-05-07 University Of Iowa Research Foundation Predicting amd with snps within or near c2, factor b, plekha1, htra1, prelp, or loc387715
ES2544265T3 (es) 2009-02-11 2015-08-28 Orion Genomics, Llc Combinaciones de polimorfismos para determinar la expresión específica de alelo de IGF2
WO2011128096A1 (en) 2010-04-16 2011-10-20 Roche Diagnostics Gmbh Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
PL2576837T3 (pl) 2010-06-04 2018-04-30 Chronix Biomedical Krążeniowe biomarkery typu kwasu nukleinowego związane z rakiem prostaty
US20140004510A1 (en) 2010-09-24 2014-01-02 Massachusetts Eye And Ear Infirmary Methods and compositions for prognosing and/or detecting age-related macular degeneration
US9458484B2 (en) 2010-10-22 2016-10-04 Bio-Rad Laboratories, Inc. Reverse transcriptase mixtures with improved storage stability
SG10201607224PA (en) 2011-08-31 2016-10-28 Hoffmann La Roche Responsiveness to Angiogenesis Inhibitors
RU2014110270A (ru) 2011-08-31 2015-10-10 Ф. Хоффманн-Ля Рош Аг Способ прогнозирования риска гипертензии, связанной с антиангиогенной терапией
US20130078252A1 (en) 2011-09-19 2013-03-28 Genentech, Inc. Combination treatments comprising c-met antagonists and b-raf antagonists
EP2768985B1 (en) 2011-10-21 2019-03-20 Chronix Biomedical Colorectal cancer associated circulating nucleic acid biomarkers
CN104066852A (zh) 2011-11-23 2014-09-24 霍夫曼-拉罗奇有限公司 对血管发生抑制剂的响应性
US9115394B2 (en) 2011-12-22 2015-08-25 Roche Molecular Systems, Inc. Methods and reagents for reducing non-specific amplification
DK3004388T4 (da) 2013-05-29 2023-08-28 Chronix Biomedical Påvisning og kvantificering af cellefrit dna fra donor i kredsløbet hos organtransplantatmodtagere
CA2943405A1 (en) 2014-03-31 2015-10-08 Debiopharm International Sa Fgfr fusions
US11708608B2 (en) 2014-11-10 2023-07-25 Genentech, Inc. Therapeutic and diagnostic methods for IL-33-mediated disorders
CN114250274A (zh) 2015-04-24 2022-03-29 阿提拉生物系统公司 利用有限核苷酸组成的引物扩增
ES2901506T3 (es) 2015-08-17 2022-03-22 Kura Oncology Inc Métodos para tratar pacientes con cáncer con inhibidores de la farnesiltransferasa
US20190119758A1 (en) 2016-04-22 2019-04-25 Kura Oncology, Inc. Methods of selecting cancer patients for treatment with farnesyltransferase inhibitors
PT3534885T (pt) 2016-11-03 2021-04-13 Kura Oncology Inc Inibidores de farnesiltransferase para usar em métodos de tratamento do cancro
US10137121B2 (en) 2017-02-21 2018-11-27 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
EP4119142A1 (en) 2017-02-21 2023-01-18 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
US10806730B2 (en) 2017-08-07 2020-10-20 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
MX2020001207A (es) 2017-08-07 2020-03-20 Kura Oncology Inc Metodos de tratamiento del cancer con inhibidores de farnesiltransferasa.
KR20220098056A (ko) 2018-02-09 2022-07-08 제넨테크, 인크. 비만 세포 매개 염증성 질환에 대한 치료 및 진단 방법
JP2022506463A (ja) 2018-11-01 2022-01-17 クラ オンコロジー， インコーポレイテッド ファルネシルトランスフェラーゼ阻害剤でがんを治療する方法
WO2020180663A1 (en) 2019-03-01 2020-09-10 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
KR20210144778A (ko) 2019-03-29 2021-11-30 쿠라 온콜로지, 인크. 파르네실트랜스퍼라제 억제제를 사용한 편평 세포 암종의 치료 방법
WO2020205387A1 (en) 2019-04-01 2020-10-08 Kura Oncology, Inc. Methods of treating cancer with farnesyltransferase inhibitors
WO2020223583A1 (en) 2019-05-02 2020-11-05 Kura Oncology, Inc. Methods of treating acute myeloid leukemia with farnesyltransferase inhibitors
EP4118236A1 (en) 2020-03-13 2023-01-18 MedImmune Limited Therapeutic methods for the treatment of subjects with risk alelles in il33
WO2024015331A1 (en) 2022-07-12 2024-01-18 Genentech, Inc. Therapeutic and diagnostic methods for multiple sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800159A (en) * 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
CA1340807C (en) * 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
KR0148265B1 (ko) * 1988-12-16 1998-10-15 에프.지이.엠 헤르만스 자가-지속 서열 복제 시스템
DE69034177T2 (de) * 1989-07-11 2005-10-27 Gen-Probe Inc., San Diego Verfahren zur Amplifikation von Nukleinsäuresequenzen

Also Published As

Publication number Publication date
FI932144A (fi) 1993-05-12
NO931709D0 (no) 1993-05-11
AU9131591A (en) 1992-06-11
ZA918965B (en) 1992-08-26
PT99500A (pt) 1992-10-30
HUT69772A (en) 1995-09-28
HU9301369D0 (en) 1993-10-28
JPH06502767A (ja) 1994-03-31
IL100040A (en) 1995-12-31
CA2096013A1 (en) 1992-05-14
EP0572417A4 (en) 1994-11-23
WO1992008800A1 (en) 1992-05-29
IE913930A1 (en) 1992-06-17
IL100040A0 (en) 1992-08-18
NO931709L (no) 1993-07-12
EP0572417A1 (en) 1993-12-08
NZ240574A (en) 1994-10-26

Similar Documents

Publication Publication Date Title
FI932144A0 (fi) Nukleinsyraamplifikation med ett oavbrutet sekvensreplikationssystem omfattande tvao enzymer
DE3683894D1 (de) Optischer verstaerker.
FI882663A0 (fi) Bestaemning av volymen av ett materialskikt med hjaelp av ett korrektionsband.
FI854796A (fi) Med en styranordning foer luftstroem foersedd ytbelaeggningskaopa foer reducering av utfaellning av belaeggningsmaterial till ett minimum pao oevre delen av en behaollare.
FI880817A (fi) Anordning foer koppling med laog foerlust av ett halvledarkopplingselement i en trepunktvaexelriktare.
KR900002541A (ko) 증폭기
FI884781A0 (fi) Staengbar behaollare med ett i en vaetska doppat skurstycke foer behandling av fingrar.
DE68927535D1 (de) Verstärker
FI870790A (fi) Anordning foer flytbar styrning av materialbanor med hjaelp av ett medium i gas- eller vaetskeform.
FI900765A0 (fi) Foerfarande foer mikrobearbetning av ytan av ett arbetsstycke med hjaelp av en laserstraole.
FI904608A0 (fi) Anordning foer oeverfoering av fjaerrvaerme till ett hetvattensystem.
FI861563A (fi) Pressverktyg med ett system foer styrning och loesgoering av ett metalband.
DE3876902D1 (de) Stromsensitiver differenzverstaerker.
FI901878A0 (fi) System foer formning och kalibrering.
FI914565A (fi) Insertion av dna med modifierade transposoner.
DE3667578D1 (de) Verstaerkeranordnung.
FI881933A0 (fi) Till ett pumphus ansluten doserare.
FI870147A0 (fi) Mikrobiologisk framstaellningsmetod.
FI893166A (fi) Foerfarande foer foerbindning av ett roerstycke till skumisolerade roerledningar.
DE3667230D1 (de) Verstaerkeranordnung.
DE68915221D1 (de) Verstärker.
DE3671685D1 (de) Verstaerkeranordnung.
FI902601A0 (fi) Haollare foer en injektionsspruta med ett kopplingsorgan foer preparatbehaollare.
DE3882942D1 (de) Abfuehlverstaerker.
FI891401A (fi) Databehandlingssystem med cyklisk databuffring och ett i ett saodant system anvaendbart vaeljarmedel foer vaeljande av minnesadresser.

Legal Events

Date Code Title Description
FD Application lapsed